COVID-19: The Impact in Oncology Care
- PDF / 2,282,373 Bytes
- 10 Pages / 595.276 x 790.866 pts Page_size
- 53 Downloads / 195 Views
COVID-19
COVID-19: The Impact in Oncology Care Upasana Ray 1 & Faisal Aziz 2 & Abhishek Shankar 3 & Aalekhya Sharma Biswas 4 & Abhijit Chakraborty 4 Accepted: 13 October 2020 # Springer Nature Switzerland AG 2020
Abstract The COVID-19 pandemic has imposed a critical challenge to the current oncology care and practices including late diagnoses, delayed anti-cancer treatment, and static clinical trials. With the increasing risk of cancer patients acquiring infection during receiving the essential care, the debate ensues on how to balance the risk factors and benefits out of the oncologic emergencies in cancer patients. In this review article, we have focused on the current global re-organization of the integrity and effectiveness of the treatment modalities depending on the patient and cancer-specific urgencies while minimizing exposure to the infection. In this review, we addressed how the worldwide oncology community is united to share therapy schemes and the best possible guidelines to help cancer patients, and to strategize and execute therapy/trial protocols. This review provides collective knowledge on the current re-structuring of the general framework that prioritizes cancer care with the available exploitation of the reduced resources and most importantly the unparalleled levels of companionship as a large health care community towards the need to offer the best possible care to the patients. Keywords SARS-CoV-2 . Cancer . SARS . MERS
Introduction In December 2019, a distinctive coronavirus (CoV) was determined to be responsible for an outbreak of potentially fatal atypical pneumonia, ultimately defined as coronavirus disease Highlights • The biology behind the SARS-CoV-2 infection and its difference from SARS and MERS. • We have discussed the current statistics on the risk of COVID-19 infection and the high susceptibility of the cancer patients towards being infected. • We have addressed the treatment prioritization with the balancing of risk and benefits depending on the patient and cancer-specific emergencies. • We provided important perspectives in a nutshell from oncology-emergencies, values, and strategic maintenance frameworks to highlight the present scenario in the field of clinical oncology. This article is part of the Topical Collection on Covid-19 * Abhijit Chakraborty [email protected] 1
Mayo Clinic, Rochester, MN, USA
2
The Hormel Institute, University of Minnesota, Austin, MN, USA
3
Lady Hardinge Medical College and Associated Hospitals, Delhi, India
4
Baylor College of Medicine, Houston, TX, USA
19 (COVID-19), in Wuhan, Hubei province, China [1]. Early cases of Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) were identified in people who visited or worked in the Huanan Wholesale Seafood Market in Wuhan. From Wuhan, China SARS-CoV-2 is dramatically spreading in several months all over the world. The disease related to SARS-CoV-2 is called coronavirus disease 2019 (COVID-19). As of Oct 21, 2020, a total of 41,118,064 confirmed COVID-19 cases and 1,129,710 death
Data Loading...
